Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 6/20 | 0.45 |
| ▸ | RAB9A | P51151 | 6/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 6/20 | 0.41 |
| ▸ | POLB | P06746 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2891422 | 0.91 | ALDH1A1 (0.47) | NPC1RAB9ASMN1; SMN2MAPTPOLB | |
| SCHEMBL4964184 | 0.88 | ALDH1A1 (0.41) | NPC1RAB9ASMN1; SMN2MAPTPOLB | |
| SCHEMBL4961190 | 0.87 | SMN1; SMN2 (0.48) | NPC1RAB9ASMN1; SMN2MAPTPOLB | |
| SCHEMBL4961200 | 0.85 | ALDH1A1 (0.41) | NPC1RAB9ASMN1; SMN2MAPTPOLB | |
| SCHEMBL4960071 | 0.85 | TP53 (0.43) | NPC1RAB9ASMN1; SMN2MAPTPOLB | |
| SCHEMBL2894559 | 0.84 | ALDH1A1 (0.47) | NPC1RAB9ASMN1; SMN2MAPTPOLB | |
| SCHEMBL4775272 | 0.84 | POLB (0.43) | NPC1RAB9ASMN1; SMN2MAPTPOLB | |
| SCHEMBL2895460 | 0.84 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2MAPTPOLB | |
| SCHEMBL4776039 | 0.83 | MAPT (0.42) | NPC1RAB9ASMN1; SMN2MAPTPOLB | |
| SCHEMBL4766403 | 0.82 | TGFBR1 (0.43) | NPC1RAB9ASMN1; SMN2MAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1893618-A2 | TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER | Nycomed GmbH (DE) | 2008-03-05 | — | — | EP | disclosed |
| WO-2006125815-A2 | TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER | NYCOMED GMBH (DE) | 2006-11-30 | — | — | WO | disclosed |